Diabetes
New data from Germany, the United States and Israel lluminates research in diabetes
Published in Obesity and Diabetes Week, July 3rd, 2006
Study 1: Dipeptidyl peptidase-IV inhibitors can restore glucose homeostasis in type 2 diabetics via incretin enhancement.
"Incretin levels approach normal physiological values following treatment with dipeptidyl peptidase (DPP)-IV inhibitors. This is in contrast to incretin levels resulting from the exogenous administration of glucagon-like peptide (GLP)-1 and its analogs, which can reach super-physiological values," a review in Germany reports.
"This review describes the role of DPP-IV inhibitors as incretin enhancers in the regulation of glucose...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Morbid Obesity
HOMA, QUICKI and MFfm offer insulin resistance measurement options in morbid obesity - Obesity Pathogenesis
Leptin may inhibit preadipocyte proliferation by modifying signals in nonadipose tissue - Obesity Pathogenesis
Macrophage-conditioned medium inhibits differentiation of 3T2-L1 and abdominal preadipocytes - Obesity Therapy
11 Beta-hydroxysteroid dehydrogenase type 1 inhibition reduces weight gain in obesity model - Obesity Therapy
Pyrimidine-diazabicyclo[3.3.0]octane series are 5-HT2C receptor agonists to combat obesity - Atherosclerosis
Diet and exercise may improve coronary artery disease risk linked to metabolic syndrome - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
